Currently in the midst of a generational transformation of its healthcare system, Egypt has more to recommend it than ever to the global life sciences investment community. Not only is the country attempting to bring its entire 100+ million population under some form of…
With the tremendous healthcare momentum that is already underway in the Gulf Cooperation Council (GCC) countries, driven by economic diversification and transformation, the future of healthcare in the region looks bright. Government initiatives such as Saudi Arabia’s…
At a crucial moment ahead of a snap general election on 25 September 2022, this new report looks back at the progress that Italy’s healthcare and life sciences sector has made in recent years and assesses its future prospects. While the country’s political winds are…
InFocus: The Future of Healthcare in the GCC
07/09/2022
With the tremendous healthcare momentum that is already underway in the Gulf Cooperation Council (GCC) countries, driven by economic diversification and transformation, the future of healthcare in the region looks bright. Government initiatives such as Saudi Arabia’s…
Having foregrounded its life sciences credentials with the establishment of manufacturing and clinical trials hubs, Spain is hoping to secure its position as a globally relevant industry player. The Iberian nation can boast an advanced healthcare system – which has…
PharmaBoardroom’s latest report, InFigures: Middle East & Africa (MENA) 2022 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. MENA may be the smallest pharmaceutical market in the world, accounting for just 2 percent…